The FDA approved gepotidacin for the treatment of uncomplicated UTIs in women and adolescent girls aged 12 years or older, GSK announced. An antibiotic stewardship intervention at urgent care ...

PwC has released its latest Global Top 100 report ranking the largest public companies by market cap as of the end of March 2024.

AbbVie (NYSE:ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved EMBLAVEO™ (aztreonam and ...

The table below is a review of notable updates that occurred in February 2025 for investigational products in development (not an inclusive list). Click on the status to view our full coverage.

Patients treated with Odactra experienced a 22% reduction in total combined rhinitis score compared with placebo. The expanded approval was supported by data from a phase 3 trial (ClinicalTrials.gov ...

The following table presents notable drug approvals of February 2025. Penmenvy (meningococcal Groups A, B, C, W, and Y vaccine) Meningococcal vaccine For active immunization to prevent invasive ...

Pediatr Infect Dis J. 2015;34(8):849-850. Piperacillin–tazobactam is a safe antimicrobial agent frequently used in pediatric patients for the treatment of complicated appendicitis, cystic ...

The recent hospitalisation of Madonna once again highlights the risks posed by bacterial infections and their potentially serious consequences for patients. The 64-year-old pop superstar is ...

This collaborative approach, alongside the FDA approval of innovative products like EMBLAVEO, has reinforced investor confidence. Despite facing challenges such as fluctuating profit margins and ...